Traumatic Brain Injury
1,082
144
178
525
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Published Results
139 trials with published results (13%)
Research Maturity
525 completed trials (49% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
7.4%
80 terminated out of 1082 trials
86.8%
+0.2% vs benchmark
7%
81 trials in Phase 3/4
26%
139 of 525 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 525 completed trials
Clinical Trials (1082)
Effect of Aerobic Exercise Training on Cardiorespiratory Function in Patients With Traumatic Brain Injury
Evaluation, Pathogenesis, and Outcome of Subjects With or Suspected Traumatic Brain Injury
Targeting Osteosarcopaenia and Multimorbidity for Frailty Prevention
Evaluation of the SCALED (SCaling AcceptabLE cDs)
Effects of Rapid-Resisted Exercise and Bright Light Therapy on Ambulatory Adults With Traumatic Brain Injury
Invasive Versus Non-Invasive Intracranial Pressure-Guided Management in Neurosurgical Patients
Prognostic Factors to Regain Consciousness
SmART-TBI: Supplementation With Amino Acid Rehabilitative Therapy in TBI
Effectiveness of Music Therapy on Level of Consciousness
HBOT Effects on First Responders' Cognition and Well-Being
Reliability and Validity of the PReFS
CoMind Early Feasibility Study
Treating Mild Traumatic Brain Injury With High Definition Transcranial Direct Current Stimulation
Optimal Cerebral Perfusion Pressure Guided Therapy: Assessment of Target Effectiveness - II
Depth Electrode Cortical Reverberation Monitoring After Traumatic Brain Injury
Treating Traumatic Brain Injury With Transcranial Direct Current Stimulation
Age Related Thresholds for Management of Severe Head Injury in Paediatrics: An Extension of STARSHIP
Acupuncture for Post-traumatic Olfactory Dysfunction: A Randomized Controlled Trial
Methylprednisolone for Moderate to Severe Traumatic Brain Injury
A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury